EXPERIENCE OF USE OF SPECIAL MOISTENING LOTION IN ATOPIC DERMATITIS
https://doi.org/10.15690/vsp.v13i1.929
Abstract
performed according to the three-point scale (0–2 points). Results: in assessment of subjective sensations after the usage of the lotion in the main group the absence of skin burning was observed in 443 (95,5%), absence of skin dryness — in 448 (96,1%) and
absence of hyperemia — in 457 (98,1%) of the children. In assessment of questionnaires of the children with atopic dermatitis absence of skin burning was found in 151 (95,6%), absence of skin dryness — in 152 (96,2%) and absence of hyperemia — in 155 (98,1%) of the patients. Moreover the drug showed high cosmetic acceptability in the both groups. Conclusions: high safety and cosmetic acceptability of the moistening lotion were confirmed both in the main group of children and in patients with atopic dermatitis.
About the Authors
E. G. BiryukovaRussian Federation
S. A. Efimova
Russian Federation
E. Yu. Varfolomeeva
Russian Federation
N. A. Fedorovskaya
Russian Federation
M. Yu. Astvatsaturova
Russian Federation
N. V. Visarova
Russian Federation
N. Yu. Savvateeva
Russian Federation
References
1. Namazova-Baranova L. S. Allergija u detej: ot teorii — k praktike. Monografija. Serija “Sovremennaja pediatrija: ot teorii — k praktike” [Child allergy: bedside approach. Study. Line “Current pediatrics: bedside approach”]. Edited by L. S. Namazova-Baranova. Moscow, Sojuz pediatrov Rossii, 2010–2011. 668 p.
2. Ogorodova L. M., Namazova-Baranova L. S., Smirnova G. I. Atopicheskij dermatit. V kn.: Pediatrija. Nac. ruk-vo. Kratk. izd. [Atopic dermatitis. Included in book: Pediatrics. National guidance. Shortened edition]. Edited by A. A. Baranov. Moscow, GJeOTARMedia, 2013. pp. 495–513.
3. Ellis C., Luger T., Abeck D. et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Brit. J. Dermatol. 2003; 148 (Suppl. 63): 3–10.
4. Simpson E. L. Atopic dermatitis: а review of topical treatment options. Curr. Med. Res. Opin. 2010; 26 (3): 633–640.
5. Smethurs D., Macfarlane S. Atopic eczema. Clin. Evid. 2002; 1785–1803.
6. Leung D. Y. Our evolving understanding of the functional role of filaggrin in atopic dermatitis. Allergy Clin. Immunol. 2009; 124: 494–495.
7. Barker J. N. et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. Invest. Dermatol. 2007; 127: 504–507.
8. Simpson E. Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. J. Dermatol. Treat. 2013; 24: 122–125.
9. Simpson E., Dutronc Y. A new body moisturizer increases skin hydration and improves atopic dermatitis symptoms among children and adults. J. Drugs Dermatol. 2011; 10: 744–749.
Review
For citations:
Biryukova E.G., Efimova S.A., Varfolomeeva E.Yu., Fedorovskaya N.A., Astvatsaturova M.Yu., Visarova N.V., Savvateeva N.Yu. EXPERIENCE OF USE OF SPECIAL MOISTENING LOTION IN ATOPIC DERMATITIS. Current Pediatrics. 2014;13(1):167-171. (In Russ.) https://doi.org/10.15690/vsp.v13i1.929